Financhill
Back

The Duckhorn Portfolio Vs. Novo Nordisk AS Industry Stock Comparison

Buy
70

NAPA
The Duckhorn Portfolio

Last Price:
$11.11
Seasonality Move:
-9.8%
Sell
23

NVO
Novo Nordisk AS

Last Price:
$85.00
Seasonality Move:
6.92%
Buy
70
The Duckhorn Portfolio (NAPA) is a Buy

Is The Duckhorn Portfolio a Buy, Sell or Hold?

  • The current The Duckhorn Portfolio [NAPA] share price is $11.11. The Score for NAPA is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
  • NAPA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $85.00. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NAPA Stock Price Chart

What is The Duckhorn Portfolio's stock price today?

  • The The Duckhorn Portfolio share price today is $11.11
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NAPA is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $85.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.

NAPA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.11 Buy
Relative Strength Index (14 RSI): 78.38 Buy
Chaikin Money Flow: 1341650 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.01 - 11.09) Buy
Bollinger Bands (100): (6.33 - 11.17) Buy

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.5 Sell
Relative Strength Index (14 RSI): 19.69 Sell
Chaikin Money Flow: 20899665 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.63 - 110.99) Sell
Bollinger Bands (100): (107.27 - 131.41) Sell

NAPA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.09 Buy
20-day SMA: 11.05 Buy
50-day SMA: 11.01 Buy
200-day SMA: 8.39 Buy
8-day EMA: 11.08 Buy
20-day EMA: 11.03 Buy
50-day EMA: 10.46 Buy
200-day EMA: 9.21 Buy

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.71 Sell
20-day SMA: 106.65 Sell
50-day SMA: 109.28 Sell
200-day SMA: 126.25 Sell
8-day EMA: 102.07 Sell
20-day EMA: 105.53 Sell
50-day EMA: 110.02 Sell
200-day EMA: 118.09 Sell

The Duckhorn Portfolio Earnings Growth & NAPA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.09 per share, and an increase next year of $0.08 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.72 per share.

The Duckhorn Portfolio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):